drugset / Trial / NCT05804591

Pregabalin in the Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy (LSG).

NCT05804591

Phase 4 Recruiting 90 enrolled Medical University of Warsaw
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this clinical trial is to assess preemptive oral pregabalin administration in the obese patients undergoing laparoscopic sleeve gastrectomy. The main aims of the study are to evaluate postoperative pain treatment and effect on the intraoperative hemodynamical stability. The participants will be divided into 2 groups: with or without preemptive pregabalin administration.

Timeline

Start
2023-04-24
Primary completion
2025-04-01
Completion
2025-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 150 mg Oral